Telo Genomics provides important actionable information to medical professionals in the management of cancer or cognitive disease.

It applies innovative, minimally-invasive analysis of genomic instability based on the three-dimensional organization of telomeres for the purpose of reducing treatment cost and improving quality of life.

Investor Contact:

Sherif Louis

Phone: 416-637-8487